Nat. Rev. Neurol. doi: /nrneurol

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Life expectancy at birth in all countries included

Figure 2 The US Centers for Disease Control and

Figure 4 Time course of the development of physiological changes

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Proposed mechanism of Guillain–Barré

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Involvement of SEMA4D in the pathogenesis

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 7 Defects in apoptosis

Figure 1 Location of HLA variants known to be associated

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Figure 1 Schematic overview of the LGI1 protein in the synapse

Figure 4 Proposed therapy scheme for anti-LGI1 encephalitis

Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain

Figure 2 Algorithm for immunosuppressive treatment

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Clinical correlates of neurodegeneration in MS

Volume 30, Issue 2, Pages (May 2001)

Figure 3 Genetic pleiotropy in ALS

Figure 4 Lifestyle and environmental factors affect

Figure 1 Evolution of multiple sclerosis

Figure 4 The molecular configuration of the CD20 molecule

Figure 4 Generation of tau seeds and spread of tau pathology

Figure 1 Zika virus transmission and clinical syndromes

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Neuromuscular junction in myasthenia gravis (MG)

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 2 Age-specific prevalence of common comorbidities

Figure 4 11C-PK11195-PET scans showing the evolution of neuroinflammation in a patient after stroke Figure 4 | 11C-PK11195-PET scans showing the evolution.

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

Figure 1 The node of Ranvier

Figure 3 Current model of immunopathogenesis in CIDP

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Biomarkers associated with different clinical phases in MS

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Logistical requirements for autologous

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Chromosomal region 15q11.2–q13

Figure 1 Clinical aspects of LGMD subtypes

Figure 1 The VEGF family of growth factors

Figure 2 Pathophysiological mechanisms in LGMD

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Representative images of skin biopsy sample

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 ADAM22 mutant proteins do not bind to LGI1

Figure 2 Histopathological features in CIDP

Action Potential.

Figure 2 Network connections of the hypothalamus

Figure 6 Multiple target epitopes exist in the N-terminal domains of Caspr2 (A) Multidomain deletion constructs of Caspr2 were generated to determine which.

Figure 1 Standard treatment scheme and antibody titer changes

Polarized Domains of Myelinated Axons

Presentation transcript:

Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.43 Figure 2 Schematic overview of the Caspr2 protein in the juxtaparanodal region of myelinated axons Figure 2 | Schematic overview of the Caspr2 protein in the juxtaparanodal region of myelinated axons. Contactin-associated protein-like 2 (Caspr2) connects to the dimerized contactin-2 (also known as TAG-1) and to disks large homologue 4 (PSD95). This complex organizes KV1 potassium channels. Patients' antibodies bind to the extracellular region of Caspr2, possibly abrogating the Caspr2–contactin-2 interaction. ADAM22, a disintegrin and metalloproteinase 22; VGKC, voltage-gated potassium channel. van Sonderen, A. et al. (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.43